|
CHSY1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.998200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.479800E-01 |
| Normal-vs-Stage2 |
7.774100E-02 |
| Normal-vs-Stage3 |
3.998600E-01 |
| Normal-vs-Stage4 |
5.445200E-01 |
| Stage1-vs-Stage2 |
5.753800E-02 |
| Stage1-vs-Stage3 |
4.111200E-01 |
| Stage1-vs-Stage4 |
6.000000E-01 |
| Stage2-vs-Stage3 |
3.192200E-01 |
| Stage2-vs-Stage4 |
3.615000E-01 |
| Stage3-vs-Stage4 |
9.286400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.728600E-01 |
| Normal-vs-AfricanAmerican |
8.207000E-01 |
| Normal-vs-Asian |
5.382000E-01 |
| Caucasian-vs-AfricanAmerican |
8.223600E-01 |
| Caucasian-vs-Asian |
5.592600E-01 |
| AfricanAmerican-vs-Asian |
5.146200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.978600E-01 |
| Normal-vs-Female |
4.440600E-01 |
| Male-vs-Female |
5.220800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.428000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.499760E-01 |
| Normal-vs-Age(61-80Yrs) |
1.574190E-01 |
| Normal-vs-Age(81-100Yrs) |
6.512600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.261600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.652100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.288400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.316800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.328600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.134000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.545800E-01 |
| Classical-VS-Follicular |
6.636100E-04 |
| Classical-VS-Other |
2.269200E-01 |
| Classical-VS-Normal |
6.695200E-01 |
| Tall-VS-Follicular |
2.337400E-01 |
| Tall-VS-Other |
5.116200E-01 |
| Tall-VS-Normal |
5.693600E-01 |
| Follicular-VS-Other |
9.108000E-01 |
| Follicular-VS-Normal |
1.728330E-02 |
| Other-VS-Normal |
1.931230E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.686300E-02 |
| Normal-vs-N1 |
7.403400E-01 |
| N0-vs-N1 |
1.316000E-01 |
|
|
